降钙素原
医学
败血症
发热性中性粒细胞减少症
中性粒细胞减少症
内科学
并发症
胃肠病学
白细胞减少症
重症监护医学
瓜氨酸
免疫学
重症监护
血液病
化疗
急性期蛋白
血液学
C反应蛋白
肝功能不全
作者
Stefan Becker,Miika Arvonen,Marika Lappalainen,Esa Jantunen,Kari J. Pulkki,Kaisa Vepsäläinen,Sari Hämäläinen
标识
DOI:10.1080/10428194.2025.2602047
摘要
Febrile neutropenia (FN) is a common complication of chemotherapy and potentially fatal. It is often associated with mucositis. Timely recognition of complications enables early supportive treatment and potentially reduces mortality. Common diagnostic parameters are often nonspecific or have slow kinetics. This study examines the applicability of mucosa-related biomarkers in the recognition of complicated course among 78 adult hematologic patients with FN after intensive chemotherapy. Plasma concentrations of citrulline, intestinal fatty acid binding protein (I-FABP), zonula occludens-1 (ZO-1) and alpha-1 acid glycoprotein (α1AGP), as well as C-reactive protein (CRP) and procalcitonin (PCT), were measured at the onset of fever and the following two days. All except ZO-1 showed a significant trend. Concentrations of CRP, PCT, citrulline and α1AGP were higher with a complicated course. Patients with severe sepsis had higher levels of PCT and lower levels of I-FABP. In conclusion, measurement of mucosa-related biomarkers might help predict the course of FN.
科研通智能强力驱动
Strongly Powered by AbleSci AI